Individual R&D projects linked to the Addendum and the Avant-Garde Aerospace and Health PERTE.

Companies.

CLOSED.

Online applications can be submitted continuously until 31/12/2025.

Partially refundable aid.

Fixed interest rate: Euribor at 1 year.

Support of up to 90% of the approved budget.

The company must contribute at least 10% of the project budget with its own resources.

Advance of up to 90% of the aid without requiring additional guarantees.

Non-refundable tranche of 20% of the aid.

Return:15 years including a shortage of 2 years.

The CDTI may require the creation of guarantees for the return of aid when the financial economic analysis of the company indicates so.

The CDTI may apply a derogation or exemption from the guarantees requested.

Minimum Eligible Budget: 175,000 euros

Minimum duration of 12 months.

Projects may not be completed later than 31/12/2026.

Funding with funds from the Recovery and Resilience Mechanism.

The actions financed must respect the principle of not causing significant harm to the environment (DNSH principle).

Yes

All supported expenses must be allocated exclusively or derived directly from the supported R&D activity.

Personnel costs; instrumental and material costs; contract research costs, knowledge and patents, consultancy and equivalent services; additional overhead costs and other project costs are eligible for assistance. Also eligible is the expense derived from the auditor’s report and the preparation of the DNSH report by ENAC-accredited entity.

Certain project activities may be subcontracted to other companies or research agencies.

Subcontracting may not exceed 65% of the eligible budget in general, being able to reach up to 80% for the biopharmaceutical sector.

Criteria for technical evaluation:

- Commercial exploitation plan of the project.

- Technology and innovation of the project.

- Capacity of the company in relation to the project.

- Assessment of socio-economic impact, gender perspective, accessibility and sustainability.

Criteria for financial evaluation:

- Analysis of the consideration of a company in crisis.

- Economic-financial and risk analysis.

- Economic and financial analysis of the project.

- Economic and financial adaptation of the company to the activities it carries out in the project.

The aid will be considered to have an incentive effect if, before starting work on the project, the beneficiary has submitted his request for aid to the CDTI in writing.

The aid is incompatible with any other public aid at European, state or regional level, with the same objectives and purpose.

The aid is incompatible with any private aid whose source of funding comes from funds of the European Union Budget (Structural Funds, European Investment Funds, or others).

These grants will be governed by the European Union and national regulations applicable to the European funds of the Recovery and Resilience Mechanism